Susquehanna International Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $48.1M | Buy |
|
|||||
|
2025
Q2 | $30.4M | Sell |
|
|||||
|
2025
Q1 | $47.2M | Buy |
|
|||||
|
2024
Q4 | $5.04M | Sell |
|
|||||
|
2024
Q3 | $3.86M | Buy |
|
|||||
|
2024
Q2 | $1.35M | Sell |
|
|||||
|
2024
Q1 | $2.82M | Sell |
|
|||||
|
2023
Q4 | $14.5M | Buy |
|
|||||
|
2023
Q3 | $6.44M | Sell |
|
|||||
|
2023
Q2 | $13.5M | Sell |
|
|||||
|
2023
Q1 | $31.2M | Buy |
|
|||||
|
2022
Q4 | $3.21M | Sell |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.19M | Sell |
|
|||||
|
2021
Q4 | $4.37M | Sell |
|
|||||
|
2021
Q3 | $4.14M | Buy |
|
|||||
|
2021
Q2 | $2.41M | Buy |
|
|||||
|
2021
Q1 | $2.73M | Sell |
|
|||||
|
2020
Q4 | $3.8M | Sell |
|
|||||
|
2020
Q3 | $6.17M | Buy |
|
|||||
|
2020
Q2 | $964K | Sell |
|
|||||
|
2020
Q1 | $5.51M | Buy |
|
|||||
|
2019
Q4 | $5.22M | Buy |
|
|||||
|
2019
Q3 | $1.35M | Sell |
|
|||||
|
2019
Q2 | $5.45M | Sell |
|
|||||
|
2019
Q1 | $7.3M | Buy |
|
|||||
|
2018
Q4 | $1.5M | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $181K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $7K | Sell |
|
|||||
|
2015
Q4 | $143K | Buy |
|
|||||
|
2015
Q3 | $365K | Buy |
|
|||||
|
2015
Q2 | $406K | Sell |
|
|||||
|
2015
Q1 | $1.61M | Buy |
|
|||||
|
2014
Q4 | $867K | Sell |
|
|||||
|
2014
Q3 | $1.23M | Buy |
|
|||||
|
2014
Q2 | $1.35M | Sell |
|
|||||
|
2014
Q1 | $1.66M | Buy |
|
|||||
|
2013
Q4 | $1.51M | Buy |
|
|||||
|
2013
Q3 | $547K | Buy |
|
|||||
|
2013
Q2 | $92K | Buy |
|